NCT05225155View on ClinicalTrials.gov

Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

February 2, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

August 31, 2019

Conditions
Infertility, FemaleThrombophiliaFertilization in Vitro
Interventions
DRUG

Enoxaparin

Women with thrombophilia were treated with 40 mg daily of enoxaparin (treated group), initiated on the day of embryo transfer, up to week 36 of gestation

Trial Locations (1)

09041000

Assistencia Materno Infantil Lambert, Santo André

All Listed Sponsors
lead

Faculdade de Medicina do ABC

OTHER

NCT05225155 - Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment | Biotech Hunter | Biotech Hunter